Clarke S - Search Results

1

Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics.

Rischin D, Ackland SP, Smith J, Garg MB, Clarke S, Millward MJ, Toner GC, Zalcberg J. Rischin D, et al. Among authors: clarke s. Ann Oncol. 2002 Nov;13(11):1810-8. doi: 10.1093/annonc/mdf305. Ann Oncol. 2002. PMID: 12419756 Free article. Clinical Trial.

2

Open label, multi-centre phase II study of raltitrexed ('Tomudex') in patients with inoperable squamous-cell carcinoma of head and neck.

Clarke SJ, Zalcberg J, Olver I, Mitchell PL, Rischin D, Dalley D, Green M, Davidson YE. Clarke SJ, et al. Ann Oncol. 2000 Feb;11(2):239-41. doi: 10.1023/a:1008369629944. Ann Oncol. 2000. PMID: 10761765 Free article. Clinical Trial.

3

Optimizing the erythromycin breath test for use in cancer patients.

Rivory LP, Slaviero K, Seale JP, Hoskins JM, Boyer M, Beale PJ, Millward MJ, Bishop JF, Clarke SJ. Rivory LP, et al. Among authors: clarke sj. Clin Cancer Res. 2000 Sep;6(9):3480-5. Clin Cancer Res. 2000. PMID: 10999732 Clinical Trial.

4

Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer.

Boyer MJ, Mitchell P, Goldstein D, Millward MJ, Olver IN, Clarke SJ, Richardson G, Davis I. Boyer MJ, et al. Among authors: clarke sj. Lung Cancer. 2001 Apr;32(1):89-94. doi: 10.1016/s0169-5002(00)00207-5. Lung Cancer. 2001. PMID: 11282433 Clinical Trial.

5

Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. a review of phase II/III trials.

Cunningham D, Zalcberg J, Maroun J, James R, Clarke S, Maughan TS, Vincent M, Schulz J, González Barón M, Facchini T. Cunningham D, et al. Among authors: clarke s. Eur J Cancer. 2002 Mar;38(4):478-86. doi: 10.1016/s0959-8049(01)00413-0. Eur J Cancer. 2002. PMID: 11872339 Review.

6

Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer.

Clarke SJ, Abratt R, Goedhals L, Boyer MJ, Millward MJ, Ackland SP. Clarke SJ, et al. Ann Oncol. 2002 May;13(5):737-41. doi: 10.1093/annonc/mdf115. Ann Oncol. 2002. PMID: 12075742 Free article. Clinical Trial.

7

Pemetrexed: single-agent and combination phase I study overview.

Boyer MJ, Rivory LP, Clarke SJ. Boyer MJ, et al. Semin Oncol. 2002 Dec;29(6 Suppl 18):18-23. doi: 10.1053/sonc.2002.37464. Semin Oncol. 2002. PMID: 12571806 Review.

8

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients.

Millward MJ, Boyer MJ, Lehnert M, Clarke S, Rischin D, Goh BC, Wong J, McNeil E, Bishop JF. Millward MJ, et al. Among authors: clarke s. Ann Oncol. 2003 Mar;14(3):449-54. doi: 10.1093/annonc/mdg118. Ann Oncol. 2003. PMID: 12598352 Free article. Clinical Trial.

9

ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study.

Smit EF, Mattson K, von Pawel J, Manegold C, Clarke S, Postmus PE. Smit EF, et al. Among authors: clarke s. Ann Oncol. 2003 Mar;14(3):455-60. doi: 10.1093/annonc/mdg099. Ann Oncol. 2003. PMID: 12598353 Free article. Clinical Trial.

10

Thymidylate synthase inhibitors.

Ackland SP, Clarke SJ, Beale P, Peters GJ. Ackland SP, et al. Cancer Chemother Biol Response Modif. 2002;20:1-36. Cancer Chemother Biol Response Modif. 2002. PMID: 12703198 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,885 results

Search Page

Filters